Investment Type: Venture Capital
Mentions in press and media 1
Date | Title | Description |
23.07.2024 | Xellar Biosystems raises angel+ round and 40 other Greater China deals worth over $431m | Xellar Biosystems, an artificial intelligence (AI) biotech firm that combines machine learning and AI with large-scale wet-lab experiments, has secured 100 million yuan ($14 million) in its angel+ funding round led by Chinese pharmaceutical... |